Aurobindo to acquire dermatology and oral solids businesses for Sandoz Inc., USA
Aurobindo to acquire dermatology and oral solids businesses from Sandoz Inc., USA Acquisition for an upfront purchase price of $0.9 billion in cash including potential upside in near term earn-out and additional potential earn-out on pipeline product in outer years. Aurobindo would become the 2nd largest generic player in the US by number of prescriptions Aurobindo […]
Aurobindo to acquire dermatology and oral solids businesses for Sandoz Inc., USA Read More »